Corporate Strategy - Life Sciences and Pharma
A rapidly changing healthcare environment and an increasingly challenging market landscape are making it difficult for life sciences companies to continue to grow and drive value for their shareholders. Increased pricing pressure, evolving market access dynamics, breakthrough innovation, evolving consumer behavior, and disruption from digitization and the entry of other nontraditional players are all forcing life sciences companies to think strategically about which aspects of their business they want to invest in, and what new avenues of growth they may want to explore.
At L.E.K., we help life sciences and pharmaceutical executives develop practical strategies to address these issues and win in a dynamic global healthcare market.
What we do
We are a leader in life sciences growth strategy. Our approach is customized for each situation, and our team brings the deep technical expertise required to determine the optimal strategy to meet our clients’ goals. Some of our core corporate strategy offerings include:
- Strategic planning: Developing a clear vision and a practical plan for achieving that vision are key success factors common to many of the most successful companies in the life sciences industry. We have experience helping life sciences companies grow via a number of different strategies, and we continue to stay on the cutting edge, observing innovative new approaches and understanding their pros and cons. This knowledge base enables us to help our clients understand their current capabilities and positioning, and then develop customized strategies to achieve their goals.
- Portfolio strategy: Given the time and expense of product development, optimizing your portfolio and investing in the most promising assets and areas are critical. We help clients determine how to allocate R&D budgets by applying tried-and-true frameworks and advanced analytics. We also help clients identify potential gaps in their portfolio, and then utilize our leading transaction support services to guide business development activity.
- Policy development: We have experience working with pharma and life sciences companies, patient advocacy groups, and governments to both analyze the impact of different healthcare policies and develop innovative approaches to improve them. We can then leverage our network of key opinion leaders to pressure-test these ideas, and help build consensus with key stakeholders about the optimal path forward.
Examples of our work
To learn more about how we help our clients, please refer to these case examples: